首页> 美国卫生研究院文献>World Journal of Surgical Oncology >Long-term oncologic outcomes of radiotherapy combined with maximal androgen blockade for localized high-risk prostate cancer

【2h】

Long-term oncologic outcomes of radiotherapy combined with maximal androgen blockade for localized high-risk prostate cancer

机译：局部放疗高危前列腺癌放疗联合最大剂量雄激素的长期肿瘤学结局

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

摘要
著录项
相似文献
相关主题

摘要

BackgroundTo assess the oncologic outcomes of radiation therapy (RT) combined with maximal androgen blockade (MAB) and prostate-specific antigen (PSA) kinetics in patients with localized, high-risk prostate carcinoma (PCa).

机译：背景为了评估局部高危前列腺癌（PCa）患者的放射疗法（RT）结合最大雄激素阻断（MAB）和前列腺特异性抗原（PSA）动力学的肿瘤学结果。

著录项

期刊名称 World Journal of Surgical Oncology
作者
Yong Luo; Mingchuan Li; Hengzhi Qi; Jiahui Zhao; Yili Han; Yunhua Lin; Zhu Hou; Yongguang Jiang;
展开▼
作者单位

展开▼
年(卷),期 2018(16),-1
年度 2018
页码 107
总页数 10
原文格式 PDF
正文语种
中图分类外科学 ; 肿瘤学 ;
关键词
Prostate cancer Brachytherapy PSA kinetics Maximal androgen blockade Radiation therapy;

机译：前列腺癌;近距离放射治疗;PSA动力学;最大雄激素阻断;放射治疗;

相似文献

外文文献
中文文献
专利

1. Long-term oncologic outcomes of radiotherapy combined with maximal androgen blockade for localized, high-risk prostate cancer [J] . Yong Luo, Mingchuan Li, Hengzhi Qi, World Journal of Surgical Oncology . 2018 ,第1期

机译：局部放疗，高危前列腺癌放疗联合最大剂量雄激素的长期肿瘤学结局
2. Combined androgen blockade achieved better oncological outcome in androgen deprivation therapy for prostate cancer: Analysis of community‐based multi‐institutional database across Japan using propensity score matching [J] . Mizuki Onozawa, Hideyuki Akaza, Shiro Hinotsu, Cancer Medicine . 2018 ,第10期

机译：联合雄激素阻断剂在前列腺癌雄激素剥夺治疗中获得了更好的肿瘤学结果：使用倾向评分匹配法分析了日本各地基于社区的多机构数据库
3. Long-term outcomes of 60 Gy conventional radiotherapy combined with androgen deprivation for localized or locally advanced prostate cancer. [J] . Hashine K, Numata K, Azuma K, Japanese journal of clinical oncology. . 2005 ,第11期

机译：60 Gy常规放疗联合雄激素剥夺治疗局部或局部晚期前列腺癌的长期疗效。
4. Role of the Androgen Receptor and PI3K/Akt in the Survival of Androgen-Refractory Prostate Cancer Cells [C] . Haojie Huang, Donald J. Tindal International Symposium on Hormonal Carcinogenesis . 2005

机译：雄激素受体和PI3K / AKT在雄激素难治性前列腺癌细胞存活中的作用
5. Duration of androgen deprivation therapy and nadir of testosterone at 20 ng/dL predict testosterone recovery to supracastrate level in prostate cancer patients who received external beam radiotherapy [D] . TAKEI, Akinori 2019

机译：雄激素剥夺治疗的持续时间和最低20 ng / dL的睾丸激素最低值可预测接受外照射的前列腺癌患者的睾丸激素恢复至超水平
6. Combined androgen blockade achieved better oncological outcome in androgen deprivation therapy for prostate cancer: Analysis of community‐based multi‐institutional database across Japan using propensity score matching [O] . Mizuki Onozawa, Hideyuki Akaza, Shiro Hinotsu, 2018

机译：联合雄激素阻断剂在前列腺癌雄激素剥夺治疗中获得了更好的肿瘤学结果：使用倾向评分匹配法分析了日本各地基于社区的多机构数据库
7. Long-term oncologic outcomes of radiotherapy combined with maximal androgen blockade for localized, high-risk prostate cancer [O] . Yong Luo, Mingchuan Li, Hengzhi Qi, 2018

机译：放射治疗的长期肿瘤结果与最大雄激素封闭式局部化，高风险的前列腺癌
8. Phase II Trial of Androgen Suppression and Radiation Therapy with Samarium-153 in Localized, High-Risk, Prostate Cancer [R] . Valicenti, R. K. 2005

机译：在局部高风险前列腺癌中使用samarium-153进行雄激素抑制和放射治疗的II期试验

Long-term oncologic outcomes of radiotherapy combined with maximal androgen blockade for localized high-risk prostate cancer

摘要

著录项

相似文献

相关主题

期刊订阅